Investing Ideas
/
Italian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Italian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

2 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	FF Fine Foods & Pharmaceuticals N.T.M	€6.90	3.0%	-22.5%	€168.9m	€12.00	PE34.8x	E30.7%	1.7%
	REC Recordati Industria Chimica e Farmaceutica	€59.65	1.1%	18.2%	€12.2b	€56.64	PE28.8x	E11.2%	2.1%

Page 1 of 1